Exploratory Grant for NIA Alzheimers Disease Research Center (P20 Clinical Trial Not Allowed) | RFA AG 20 023

Opportunity Information: Apply for RFA AG 20 023

The Exploratory Grant for NIA Alzheimer's Disease Research Center (P20 Clinical Trial Not Allowed), funding opportunity number RFA-AG-20-023, is a National Institutes of Health (NIH) grant designed to help organizations lay the groundwork for a full Alzheimer's Disease Research Center (ADRC) award under the P30 mechanism. The main idea is to support early-stage planning and coordinated start-up activities that build the collaborations, shared resources, and overall research infrastructure an institution would need to successfully operate an ADRC. In practical terms, this opportunity is meant for groups that are not yet running a P30-level center but want to organize the people, systems, and institutional capacity required to become competitive for one.

The purpose of the award is not to fund a mature, fully operating center right away, but to fund the steps that make a future center possible. That includes initiating collaborative activities across departments or partner institutions, establishing governance and administrative structures, developing core capabilities (such as standardized procedures, data systems, recruitment pipelines, or clinical and research coordination processes), and creating the operational framework that aligns with what an NIH-funded ADRC is expected to have. Because the announcement is explicitly "Clinical Trial Not Allowed," the work proposed under this P20 should not involve conducting clinical trials; applicants need to shape the project around infrastructure development, planning, coordination, and other non-trial activities that strengthen readiness for a P30 application.

This is a discretionary grant in the Health funding activity category, listed under CFDA number 93.866. The agency is NIH, and the opportunity was created on May 30, 2019, with an original closing date of October 9, 2019. The listed award ceiling is $750,000. The source information does not specify the expected number of awards in the provided field, so applicants would typically look to the full announcement for any details on anticipated funding levels or paylines beyond the ceiling amount.

Eligibility is broad across U.S.-based entities and includes multiple levels of government (state, county, city or township, and special district governments), independent school districts, public and state-controlled institutions of higher education, private institutions of higher education, federally recognized Native American tribal governments, and Native American tribal organizations that are not federally recognized tribal governments. It also includes public housing authorities/Indian housing authorities, nonprofit organizations both with and without 501(c)(3) status (as long as they are not institutions of higher education in those nonprofit categories), for-profit organizations other than small businesses, and small businesses. The announcement also highlights additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible agencies of the federal government, and U.S. territories or possessions.

At the same time, the opportunity is clearly limited to domestic applicants and domestic project components. Non-domestic (non-U.S.) entities, including foreign organizations and foreign institutions, are not eligible to apply. In addition, non-domestic components of U.S. organizations are not eligible, and foreign components, as NIH defines them in the NIH Grants Policy Statement, are not allowed. In other words, the work supported by this grant must be planned and carried out without foreign components, and applicants need to structure collaborations and project activities accordingly.

Overall, this FOA is best read as a stepping-stone mechanism: it supports institutions that are building toward an ADRC by funding the early infrastructure and coordination work needed to develop an Alzheimer-focused research center that can later meet the expectations of the P30 ADRC program.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "Exploratory Grant for NIA Alzheimers Disease Research Center (P20 Clinical Trial Not Allowed)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
• This funding opportunity was created on 2019-05-30.
• Applicants must submit their applications by 2019-10-09. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $750,000.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for RFA AG 20 023

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: